INTRODUCTION
A developing area of neurological and psychiatric research is finding possible associations between infectious agents and central nervous system (CNS) pathological conditions for which no pathogen has been documented to be directly responsible. To implicate viruses in CNS pathology, an efficient method of detecting and identifying these agents in clinical samples is necessary.
The most commonly used high sensitivity viral detection technologies are molecular-based methods using PCR or reverse transcription PCR (RT-PCR). The main limitation of existing PCR methodology for viral detection resides in the difficulty of designing compatible multiplex primer sets for large numbers of viruses to be screened in a single assay, which means that this approach tends to be restricted to a limited number of viral families. Serial analysis of gene expression (SAGE) and differential display are powerful highthroughput methodologies. They are, however, time-consuming and require careful optimization (1) . Previous attempts to identify differentially expressed transcripts in complex neuropsychiatric disorders, such as schizophrenia, have shown the necessity of screening a large sample set in order to rule out medication effects and normal individual variation when attempting to determine disease association (2) . DNA microarrays stand out for their simplicity, comprehensiveness, data consistency, and high-throughput (3) .
DNA pathogen microarrays have been described that target known open reading frames (ORFs) for single (4) or multiple pathogen detection (5) , allowing analysis of many virally encoded genes. Gene expression studies for a single pathogen have identified patterns of immediate early, early, or late gene expression for some herpesviruses (6) (7) (8) and established lytic expression profiles of viral genes following reactivation from latency (9) (10) (11) . A series of important studies by Striebel and colleagues (12) described a microarray-based platform for the detection of six human herpesviruses (HHVs) in a single assay with high sensitivity, specificity, and reproducibility (1, 12, 13) . Furthermore, gene expression studies for high-throughput detection of respiratory viruses allowed both analysis of human clinical samples (5) and viral discovery of an uncharacterized coronavirus using a wider pan-viral microarray (2) . A DNA RESEARCH REPORT chip based on conserved regions of the reverse transcriptase gene has also been reported for the detection of a wide variety of human and mammalian exogenous and endogenous retroviruses (3) . DNA microarrays for the detection of eight human viruses implicated in acquired immunodeficiency syndrome (AIDS) pathogenesis and cerebrospinal fluid (CSF) infections have been described (14, 15) . Microarrays for viral detection and genotyping have also been used to detect human rotaviruses (16, 17) , papillomaviruses (18, 19) , orthopoxviruses (20) , adenoviruses (21) , and the influenza virus (22) .
By measuring the expression of hundreds or thousands of genes simultaneously, microarrays can yield important information about disease, genotype, and response to drugs. However, little work has been done to extend microarray technology to the identification and characterization of CNS pathogens. For this purpose, we developed a platform that was able to detect expression levels of hundreds of unique RNA sequences derived from pathogenic agents. A set of long oligonucleotides (60-mer) was designed based on ORFs from highly conserved regions within viral families as well as heterogenic regions characterized by individual subfamilies. In addition, genes reflecting different stages of pathogenic infection were included in the oligonucleotide set to enable the chip to potentially define the stage of the viral infection. A total of 715 unique oligonucleotides, representing approximately 100 pathogens capable of infecting the CNS, were immobilized on a glass surface for pathogen detection. The sensitivity, dynamic range, and reproducibility of the microarray platform were evaluated using tissue culture cell lines and postmortem brain tissue known to be infected with diverse pathogens.
MATERIALS AND METHODS

Microarray Design
Oligonucleotides representing double-stranded DNA (dsDNA), double-or single-stranded RNA (dsRNA or ssRNA), delta and retroid viruses, bacteria, and parasites were incorporated on the microarray. Human endogenous and exogenous retroviruses, herpesviruses, and Toxoplasma gondii were more extensively covered because of previous cerebrospinal fluid and postmortem brain findings in schizophrenia patients (23) (24) (25) . Other viral families interrogated by the oligonucleotide array included: picornaviruses (polio and hepatitis A); flaviviruses (encephalitis); pestiviruses (bovine viral diarrhea virus); hepaciviruses (hepatitis C); coronaviruses, caliciviruses, paramyxoviruses, bunyaviruses, delta viruses (hepatitis D); hepadnaviruses (hepatitis B); papillomaviruses, polyomaviruses, adenoviruses, and poxviruses.
Pathogen oligonucleotide sequences (60-mer) were designed according to ORF sequences obtained from Entrez Genome and Nucleotide Databases (www.ncbi.nlm.nih.gov/entrez/query. fcgi). The probe selection was based on the criteria for specificity, sensitivity, and uniformity (26, 27) using Array Designer 2.02 software (PREMIER Biosoft International, Palo Alto, CA, USA). The defined specificity of each oligonucleotide was achieved using a BLASTn (28) search against human genome and transcriptome databases as well as the microbial database. Targeted gene sequences were first filtered to mask off segments containing low compositional complexity and sequence repeats and then used for probes designed by selecting unaligned regions to avoid cross-hybridization.
Sensitivity and uniformity were achieved by selecting probes within a melting temperature (T m ) mean = 74.97 (sd = 2.64) and a GC% content mean = 44.37 (sd = 4.95). T m calculations were based on the total concentration of the annealing oligonucleotides of 0.25 nM, as suggested by Rychlik et al. (29) and a 50-mM [Na + ] concentration.
Both entropy and enthalpy calculations were based on the thermodynamic library of all 10 Watson-Crick DNA nearest-neighbor interactions determined by SantaLucia et al. (30) .
Gene-specific probes were rated according to metric parameters such as T m , GC% content, and secondary structures (e.g., self-dimers, hairpins, repeats, and runs) and generally selected with 3′ end bias within a 1-kb region. Two to three probes representing the same gene at different sequence positions were designed according to the above criteria to enhance probe specificity. If no probes met the criteria, that particular gene was not included on the array. Oligonucleotides derived from housekeeping human genes were designed using these same criteria and included on the microarray as positive internal controls. Synthetic oligonucleotide probes (Operon-Qiagen, Valencia, CA, USA) were solubilized in 3× standard saline citrate (SSC) at a concentration of 50 pmol/μL and spotted in duplicate on each poly-Llysine-coated glass slide (nciarray. nci.nih.gov/reference/NCIReference. shtml). Each array was configured in 4 × 20 × 20 format and post-processed using standard procedures. Among 715 oligonucleotides, 567 were derived from specific viruses, 120 were derived from housekeeping human genes, 17 from parasites, and 11 from bacteria (see Supplementary Table S1 online at www.BioTechniques.com for a complete list of pathogen oligonucleotide sequences represented on the microarray).
Viral Cell Lines
The human teratocarcinoma cell line, Tera-1 (31), known to produce human teratocarcinoma-derived virus (HTDV)/human endogenous retrovirus (HERV)-K particles (32) was used to validate the probes used for detection of endogenous retrovirus HERV-K. Tera-2 (31), which does not produce the virus particles, was used as a negative control. The human cytotrophoblast cell line 3A, transformed by simian virus 40 (SV40), ts30 (33) , and a retrovirus packaging cell line PG13 derived from TK-NIH/3T3 cells (34), were both purchased from the ATCC (Manassas, VA, USA). These cell lines were used to validate the SV40 and the mammalian type C retrovirus Moloney murine leukemia virus (MMLV) probes, respectively. Two Epstein-Barr virus-transformed lymphoblast B cell lines were used to validate the EpsteinBarr virus probes.
Human neuroepithelioma cells, SK-N-MC (ATCC), were seeded in 6-well plates and inoculated in 6 different experimental conditions with herpes simplex virus 1 (HSV-1) strain HF [multiplicity of infection (MOI) range = 3 × 10 -1 to 3 × 10 -5 pfu/cell], human herpes cytomegalovirus (HCMV) strain Towne (MOI range = 2.4 × 10 -1 to 2.4 × 10 -5 pfu/cell), or virus diluent (cell growth medium, mock infected). The cells were harvested 24 h postinfection, and total RNA was isolated from the cell lysates. These assays, containing different amounts of viral load, were used to validate sensitivity and specificity in the detection of both herpesviruses.
Postmortem Brain Tissue
Frozen blocks of the dorsolateral prefrontal cortex, Brodmann area 46, were obtained from four postmortem specimens in the Stanley Medical Research Institute (Bethesda, MD, USA) Brain Collection. These tissues were homogenized in lysis buffer, DNA was extracted using the Wizard ® Genomic DNA Purification Kit (Promega, Madison, WI, USA) and subsequently used for the PCR studies. Viral presence in the samples was first detected by nested PCR and further comfirmed by pathogen microarray studies. HHV-6 sequences were detected in two of the four samples by nested PCR as previously described (35) .
Parietal lobe and pons frozen blocks were obtained from a fifth postmortem specimen donated by the National NeuroAIDS Tissue Consortium (36) . The patient was diagnosed with hepatocellular carcinoma and pulmonary metastasis. The cause of death was an acute diverticulitis with rupture. The histology showed a mild HCMV encephalitis, with scattered microglial nodules and rare inclusions. Due to the mildness of the infection, a nested PCR assay for HCMV was performed to confirm HCMV presence in these frozen tissues as previously described (35) .
Amplification of Antisense RNA, Sample Labeling, and Hybridization
Replicate comparisons (cell line/ reference) between aliquots of the same biological samples were used in all of the experiments performed. Total RNA from virally infected or noninfected cell cultures was isolated using an RNeasy ® Mini Kit with a QIAshredder column (both from Qiagen) and measured for quality using the Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA). Tissue samples from frozen blocks were homogenized in TRIzol ® solvent (Invitrogen, Carlsbad, CA, USA), and total RNA was isolated per the product protocol. A subsequent cleaning was performed using an RNeasy Total RNA Isolation Kit (Qiagen). Total RNA (3 μg) was amplified as previously described (37) . The amplified target antisense RNA was reverse transcribed into cDNA with the incorporation of Cy™3-dUTP (green, reference sample) or Cy5-dUTP (red, test sample) according to the standard target labeling protocol for cDNA microarrays (38) . The reference RESEARCH REPORT sample was generated from pooled total RNA consisting of six control cases of postmortem brain tissue. Test and reference samples were then cohybridized on the pathogen microarray chip.
Data Collection and Analysis
The arrays were scanned using a GenePix ® 4000B scanner (Axon Instruments, Union City, CA, USA) with GenePix 4.1 software at 10 μm per pixel. Fluorescence saturation was limited to <1% of spots, and intensities between the two channels were balanced by adjusting the photomultiplier tube (PMT) according to the histogram chart. The array images with corresponding data files were exported to the mAdb-NCI BioInformatics database developed by the Center for Information Technology [CIT; National Institutes of Health (NIH), Bethesda, MD, USA]. The mean signal intensity and ratio from duplicated spots were averaged to enhance data reproducibility.
Reliable hybridizations were defined as those with spot sizes >30 μm and fluorescent intensity in both channels >300 after background subtraction. Intensity data were normalized by Lowess smoother algorithm (39) using BRB ArrayTools 3.1 developed by NIH (linus.nci.nih.gov/BRB-ArrayTools. html). Log 2 ratios of normalized intensity (test versus reference) were then used for comparative measures of a cell line against the reference. The data distribution of the microarray platform was defined following the set of methods described by Hollingshead et al. (40) . Duplicated arrays were run for the MMLV sample hybridized against itself (MMLV versus MMLV) and for the SV40 sample self-self hybridization (SV40 versus SV40) from technical replicates from the same biological sample. Oligonucleotide probes with a reproducible ratio and intensity between duplication arrays and different source samples are defined as concordant probes with a log 2 ratio distribution between 0-0.56 (ratio between 1-1.48). Outliers with a ratio >1.48 account for 4.5% of the probes. These discordant probes were eliminated from data analysis due to possible labeling bias. Based on the concordant probes, potential positive pathogen calls were defined as those spots with an absolute log 2 ratio of intensity >0.56 (ratio >1.48), corresponding to 2 sd above the noise of the microarray. A positive call was defined as log 2 ratio of intensity >0.84 (ratio >1.76), which corresponds to 3 sd above noise. Hierarchical clustering and data visualization were performed using Gene Cluster and Tree View (Stanford University, Stanford, CA, USA).
RESULTS
We developed a pathogen detection array that contains probes targeting the parasite T. gondii, several bacteria, and a broad array of viruses. In this study, we focus on the applicability of the array for detecting and discriminating viral transcripts in infected cell lines and clinical samples.
Data Distribution for the Microarray Platform
Reproducible data from duplicate hybridizations of self-hybridizations in both MMLV and SV40 cell lines were observed (Figure 1 ). Data distribution for the microarray platform demonstrated a normal distribution of log 2 ratios within a relatively narrow range, with 95.5% of replicate measures falling within a log 2 ratio of 0.56 of the mean when probes were filtered for concordant spot measures as described in Materials and Methods (Table 1) . Outlier data (log 2 ratio > 0.56) was avoided for further analysis due to labeling bias.
To further validate the concordant probes, the antisense RNA from the MMLV-infected cell line was cohybridized with reference antisense RNA with differential labeling in duplicate experiments. MMLV-specific probes generated ratios greater than 0.56, suggesting a possible specific hybridization. The same result was achieved in a duplicate experiment (Figure 2) . A robust correlation (R 2 = 0.72 for the comparison MMLV reference and R 2 = 0.82 for the AC37 postmortem brain sample-reference comparison) was noted when replicate experiments were compared using all probes (1442). To enrich virus-specific concordant probes, further data filtration eliminated spots with signals ≤300 and absolute log 2 ratios ≤0.56, achieving an improved correlation R 2 = 0.83 (158 genes) for duplicated MMLV-reference arrays and R 2 = 0.86 (10 genes) for the AC37-reference arrays.
Sensitivity, Specificity, and Spectrum of Viral Detection
RNA samples extracted from SK-N-MC cells infected with decreasing amounts of HSV-1 (range = 1 × 10 6 to 1 × 10 2 pfu/mL) were used to determine the sensitivity of the array with respect to α herpesviruses. Experimental samples (labeled with red) were cohybridized with reference samples (labeled with green) on the pathogen chip. As shown in Figure  3A , hybridization results showed a systematic viral load titration effect mainly reflecting genes associated with early HSV infection: polymerase gene (probe: HSV-2), helicase-primase complex (HSV-1 UL42), uracil DNA glycosylase (HSV-2 UL2), and late HSV infection: glycoprotein B (HSV-2 gB). The immediate early gene for the short unique region (probe: HSV-1 S1) Scatter plot compares replicate array data sets using the same test MMLV and reference samples. Data are represented as normalized log 2 ratios of filtered data by eliminating intensities ≤300 and absolute log 2 ratio intensities ≤0.56. Ratios for the first MMLV/reference comparison are plotted on the x-axis; the replicate comparison is plotted on the y-axis. MMLV, Moloney murine leukemia virus.
was also up-regulated, suggesting an active virus replication status.
Due to the high percentage of identity between HSV-1 and HSV-2 (e.g., 95.5% between the polymerase genes) (41, 42) , cross-hybridization of HSV-1 with HSV-2 was observed. The HSV-1-specific probe designed for the short unique region S1 confirms the presence of HSV-1.
The same approach was applied to HCMV dilution experiments. SK-N-MC cells were infected with decreasing amounts of HCMV (range = 7 × 10 5 to 7 × 10 1 pfu/mL) to determine the sensitivity of the array in respect to β herpesviruses. The results from these studies ( Figure 3B ) demonstrate that HCMV can only be detected at higher viral inputs (7 × 10 4 and 7 × 10 5 pfu/ mL) by the current method. Probes for viral delayed early infection-related genes were also detected in HCMVinfected cell lines; for example, the probe for the major delayed early gene (HCMV IRL7) and the cytoplasmic glycoprotein (HCMV US9).
The serial HSV-1 or HCMV infection experiments were also used to validate the array specificity of viral detection. Table 2 lists probes specific for HSV with log 2 ratios >0.56 and for HCMV with log 2 ratios <0.56 in the array using cell lines infected with HSV-1 as test sample, demonstrating the specificity of these probes for HSV. Table 3 denotes HCMV-specific probes with log 2 ratios >0.56 and HSVspecific probes with log 2 ratios <0.56 in the array using cell lines infected with HCMV, demonstrating the specificity of these probes for HCMV.
To validate the detection capacity of the pathogen microarray for different viruses, multiple virally infected cell lines were tested. For the detection of retroviruses, total RNA was extracted from a human teratocarcinoma cell line (Tera-1) known to produce human teratocarcinoma-derived viral (HTDV)/HERV-K particles (32) . Tera-2 was used as a negative viral control. Fluorescent labeled antisense RNA was cohybridized with reference antisense RNA as described in Materials and Methods. Gene expression data, in log 2 ratios for these probes, indicate viral transcript expression of the HERV-K10 polymerase gene (probes: HERV pol, HERV-K10, and HERV-K10 pol) and HERV-(K) 91 (probe: HERV-K) (Figure 4 ). HERV-(K) 91 is expressed only in human teratocarcinoma cells and is similar to HERV-K pol. The detection level of these transcripts was highest for the probe HERV-(K) 91 with a log 2 ratio of 11.60. Log 2 ratios for the probes HERV pol, HERV-K10, and HERV-K10 pol were 5.58, 2.80, and 5.26, respectively. The HERV-K10/ HUMMTV probe, which is directed against a putative endogenous retrovirus with partial homology to HERV-K10, did not generate a detectable signal, suggesting that the specificity of the array is adequate to discriminate between related sequences.
Data for the detection of MMLV expression in PG13 cells, a hybrid retrovirus packaging cell line derived from TK-NIH/3T3, indicate gene expression of the MMLV polymerase gene (probes: MMLV and MMLVpol, with a log 2 ratio of 3.41 and 2.84, respectively) and envelope gene (MMLVenv with a log 2 ratio of 4.76) (Figure 4) .
In order to detect SV40 and EpsteinBarr, total RNA was extracted from a human cytotrophoblast cell line transformed with SV40 ts30 and from two lymphocyte Epstein-Barr virus (EBV)-infected cell lines. Amplification of antisense RNA and cohybridization were performed as described in Materials and Methods. The results shown in Figure 4 demonstrate that probes representing transcripts for the major structural protein (SV40-CPC/ MEN and SV40), and the large tumor (T) antigen (SV40-4A) are highly expressed. The large T antigen is an early expressed gene, encoding proteins for viral replication. It also plays a role in viral maturation by influencing the phosphorylation of capsid proteins. The major structural protein, VP1, is a late expressed gene in viral infection. Transcription of the late genes occurs from activation of the late promoter by binding of the large T antigen to the 72-bp repeats upstream of the transcription site. The corresponding log 2 ratios were as follows: the SV40-CPC/MEN probe was 4.98, the SV40 probe was 5.19, and the SV40-4A probe was 5.23. Gene-specific probes for EBV were detected in both lymphocyte EBV-infected cell lines as exemplified by the antigen protein D gene probe (EBV BMRF1early) with a log 2 ratio change between 3.52 and 4.29. The expression of immediate early genes encoding viral transactivators that drive the lytic cascade of the virus suggest an acute infection in both B lymphocyte cell lines. The two EBV-transformed cell lines (EBV-Kime and EBV-Mel) also generated positive signals for the HERV-K10/HUMMTV probe. This is not entirely unexpected because these cell lines were infected using supernatants obtained from the EBV packaging RESEARCH REPORT cell line B95-8, which is known to harbor an uncharacterized infectious type D retrovirus (43) . The signal may therefore reflect homology between the HERV-K10/HUMMTV sequence and the infectious type D retrovirus described in these cell lines.
Postmortem Analysis
Based on the validation results with infected cell lines, we next examined whether the pathogen arrays could be used to detect viral gene expression in clinical samples. Six postmortem brain samples were analyzed, including two control tissue samples (no known viruses), two HHV-6 positive samples, and two samples from a case of HCMV encephalitis. As with the cell line samples, the microarray analysis of these samples was performed using a blind experimental setup. As shown in Figure 5A , pathogen array analysis of the HCMV-infected tissue generated log 2 ratios that indicated positive HCMV viral transcript expression of the immediate early (HCMV UL109) and the immediate early transcriptional regulator (HCMV UL122) genes. Probes representing the viral delayed early HCMV infection-related genes such as the major delayed early gene (HCMV IRL4) and the cytoplasmic glycoprotein (HCMV US9) were also detected in these brain samples. HCMV IRL4 gene had the highest expression levels, with a log 2 ratio of 1.41 in the pons (sample 4) and 0.95 in the parietal lobe (sample 3). HCMV UL109 gene expression was also high in both pons and parietal lobe samples, as signified by log 2 ratios equal to 1.43 and 0.70, respectively. Log 2 ratios in the pons for the HCMV US9 and HCMV UL122 probes were 0.79 and 0.96, respectively.
The results for hybridization to the HHV-6 probe set are shown in Figure  5B . Positive hybridization signals from cDNA derived from HHV-6 infected brain tissue (samples 5 and 6) indicate viral transcript expression of the immediately early transcription unit (HHV-6-IE2hom) and the large tegument protein (HHV-6A-tegu). Log 2 ratios for the probe HHV-6-IE2hom were 0.78 and 0.77, respectively, for the two prefrontal cortex samples. Log 2 ratios for the probe HHV-6A-tegu were 0.95 and 0.93, respectively.
DISCUSSION
We have developed a microarray-based CNS pathogen detection chip that consists of a set of long oligonucleotides (60-mer) designed from ORFs of nearly 100 pathogens. The array contains probes for the parasite T. gondii and several bacteria, but focuses on viral agents, including endogenous and exogenous retroviruses, as well as dsDNA, dsRNA, ssRNA, and delta viruses. Including oligonucleotides derived from highly conserved regions potentially allows for the detection of both known pathogens as well as novel agents sharing common regions Cells were incubated with from 1 × 10 6 to 1 × 10 2 pfu/mL HSV-1 or from 7 × 10 5 to 7 × 10 1 pfu/mL HCMV for 24 h. The expression of 7 genes measured under 6 experimental conditions is represented after applying filtering criteria for selecting genes with a log 2 ratio intensity >0.56 (ratio >1.48). Descriptions of viral yield (pfu/ mL) appear above each column, whereas gene identifiers appear to the right of each row. Gene expression ratios are displayed by assessing progressively brighter shades of color to log 2 ratios that increasingly deviate from zero. with known pathogens. For example, including probes for animal retroviruses may allow for the detection of homologous HERVs sharing homology. In addition, by including genes within different functional groups (e.g., immediate early, early, or late genes for the herpesviruses), the microarray has the potential to define different stages of pathogen infection.
To validate the microarray platform for virus detection, we used virally infected cell lines and postmortem brain tissue with known viral infection status to detect different viruses and their functional stage. We also examined the performance of the microarray platform for reproducibility, sensitivity, and specificity.
The studies in the infected cell lines detected the endogenous (HERV-K) and exogenous (MMLV) retroviruses, herpesviruses (HSV-1, EBV, and HCMV), and SV40. The serial dilution experiments for HSV-1 clearly demonstrated a dose-dependent effect of viral infection, suggesting a relatively high sensitivity and specificity. The current microarray technique can detect HSV-1 at levels as low as 1 × 10 3 pfu/mL, equal to an MOI of 3 × 10 -4 pfu/cell. The estimation of viral genome copy number for HSV-1 was based on the previous publication that 1 pfu equals 100 viral genomes (44) . One × 10 3 pfu/ mL equals 1 × 10 5 viral genomes (0.3 viral genomes/cell). In cerebrospinal fluids from patients with HSV encephalitis, 2 × 10 7 copies of the HSV-1 viral genome per milliliter has been reported (45) . Overall, the detection of viral-specific gene expression by the pathogen oligonucleotide array correlates not only with the specific infected viral type but also with the viral cycle stage.
The serial dilution experiments demonstrate the microarray is less sensitive for HCMV than for HSV-1. However, it is still highly sensitive considering that the MOI in these cultures is very low; less than 1 pfu/ cell (MOI range = 3 × 10 -1 to 3 × 10 -5 pfu/cell) as opposed to other studies that used a MOI of 5 pfu/cell (7, 46) . Low abundance transcripts and/or poor design of the target-probe may explain these sensitivity differences.
Most of the HCMV RNAs present in the infected cells are transcribed from the DNA genome of the infecting virus. This is the case of the cytoplasmic glycoprotein US9 (47) . However, IRL7 is one of the few virion messenger RNAs (mRNAs) delivered to the host cell cytoplasm when the viral envelope fuses with the plasma membrane. Its translation occurs after virus entry in the absence of new transcription (46) . This different source of mRNA may explain higher viral dose detection for the virion mRNA represented by the HCMV IRL7 probe as opposed to the transcribed HCMV US9 mRNA probe.
Positive hybridizations on viralspecific probes indicated viral transcript expression of HCMV RNAs were also detected in postmortem brain samples from two different areas, parietal lobe and pons. These probes represent two virion mRNAs (UL109 and IRL4) and two RNAs transcribed from the DNA genome of the infecting HCMV virus (US9 and UL122) (46) . Two conclusions can be inferred from these results. First, the regional differences in intensity values between parietal lobe and pons are probably due to different viral loads and second, virion mRNAs seem to be consistently more abundant transcripts than the RNAs transcribed from the DNA genome, based on stronger signal intensity detection.
Our findings suggest that the arraybased platform described here is able to detect a broad spectrum of viruses in a single assay while simultaneously discriminating among different stages of viral infection. This method may be used to provide evidence of viral infection in postmortem tissue from psychiatric and neurologic patients as well as a wide range of other diagnostic categories. Our validation of this pathogen microarray provides proof of concept for the use of array-based technology in the detection and identification of CNS pathogens. (5 and 6). The expression data are measured in prefrontal cortex (1, 2, 5, and 6), parietal lobe (3), and pons (4). The expression of 6 genes is represented after applying filtering criteria for selecting genes with a log 2 ratio intensity > 0.56 (ratio > 1.48). Gene expression ratios are displayed by assessing progressively brighter shades of color to log 2 ratios that increasingly deviate from zero. (A) Heat map displaying the results for the control brains (noninfected) and HCMV encephalitis brain, representing the following detected genes: the immediately early gene (HCMV UL109), the immediately early transcriptional regulator (HCMV UL122), the major delayed early gene (HCMV IRL4), and the cytoplasmic glycoprotein (HCMV US9). (B) Heat map displaying the results of the control (noninfected) and HHV-6 infected brains representing detected expression of the immediately early transcription gene (HHV-6-IE2hom) and the large tegument protein gene (HHV-6A-tegu). HHV, human herpesvirus, HCMV, human herpes cytomegalovirus.
